MYR 4.33
(-1.59%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 44.59 Million MYR | -31.64% |
2022 | 65.23 Million MYR | 5.06% |
2021 | 62.09 Million MYR | 154.59% |
2020 | 24.39 Million MYR | -17.48% |
2019 | 29.55 Million MYR | 33.17% |
2018 | 22.19 Million MYR | 40.93% |
2017 | 15.74 Million MYR | 27.04% |
2016 | 12.39 Million MYR | 59.73% |
2015 | 7.76 Million MYR | 632.17% |
2014 | 1.06 Million MYR | -81.27% |
2013 | 5.66 Million MYR | 53.51% |
2012 | 3.68 Million MYR | 228.61% |
2011 | 1.12 Million MYR | 152.45% |
2010 | -2.13 Million MYR | -118.25% |
2009 | 11.72 Million MYR | 28.46% |
2008 | 9.12 Million MYR | 11.28% |
2007 | 8.19 Million MYR | -14.59% |
2006 | 9.6 Million MYR | -3.88% |
2005 | 9.98 Million MYR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q4 | 12.48 Million MYR | 82.7% |
2023 Q3 | 6.83 Million MYR | -41.17% |
2023 FY | 44.59 Million MYR | -31.64% |
2023 Q2 | 11.61 Million MYR | -14.96% |
2023 Q1 | 13.66 Million MYR | 4.37% |
2022 Q1 | 18.24 Million MYR | 12.34% |
2022 Q2 | 16.41 Million MYR | -10.03% |
2022 Q3 | 17.49 Million MYR | 6.61% |
2022 Q4 | 13.08 Million MYR | -25.19% |
2022 FY | 65.23 Million MYR | 5.06% |
2021 Q1 | 14.91 Million MYR | 19.93% |
2021 Q3 | 17.03 Million MYR | 22.53% |
2021 Q4 | 16.23 Million MYR | -4.7% |
2021 FY | 62.09 Million MYR | 154.59% |
2021 Q2 | 13.9 Million MYR | -6.8% |
2020 Q1 | 2.47 Million MYR | -68.64% |
2020 Q3 | 6.24 Million MYR | 93.61% |
2020 FY | 24.39 Million MYR | -17.48% |
2020 Q4 | 12.43 Million MYR | 99.15% |
2020 Q2 | 3.22 Million MYR | 30.13% |
2019 Q4 | 7.9 Million MYR | 3.78% |
2019 FY | 29.55 Million MYR | 33.17% |
2019 Q3 | 7.61 Million MYR | -14.41% |
2019 Q1 | 5.13 Million MYR | -21.29% |
2019 Q2 | 8.89 Million MYR | 73.27% |
2018 Q2 | 4.83 Million MYR | -14.86% |
2018 FY | 22.19 Million MYR | 40.93% |
2018 Q4 | 6.52 Million MYR | 26.28% |
2018 Q3 | 5.16 Million MYR | 6.98% |
2018 Q1 | 5.67 Million MYR | 1.78% |
2017 Q3 | 3.66 Million MYR | -12.88% |
2017 Q2 | 4.2 Million MYR | 82.88% |
2017 FY | 15.74 Million MYR | 27.04% |
2017 Q1 | 2.3 Million MYR | 19.16% |
2017 Q4 | 5.57 Million MYR | 52.05% |
2016 Q3 | 4.58 Million MYR | -20.31% |
2016 FY | 12.39 Million MYR | 59.73% |
2016 Q4 | 1.93 Million MYR | -57.88% |
2016 Q2 | 5.75 Million MYR | 4324.62% |
2016 Q1 | 130 Thousand MYR | -95.46% |
2015 Q2 | 591 Thousand MYR | -83.73% |
2015 Q1 | 3.63 Million MYR | 368.04% |
2015 Q3 | 676 Thousand MYR | 14.38% |
2015 Q4 | 2.86 Million MYR | 323.37% |
2015 FY | 7.76 Million MYR | 632.17% |
2014 Q4 | 776 Thousand MYR | 4.86% |
2014 Q3 | 740 Thousand MYR | -67.9% |
2014 FY | 1.06 Million MYR | -81.27% |
2014 Q2 | 2.3 Million MYR | 183.48% |
2014 Q1 | -2.76 Million MYR | -178.26% |
2013 Q2 | 17 Thousand MYR | 100.51% |
2013 Q3 | 5.46 Million MYR | 32023.53% |
2013 Q4 | 3.52 Million MYR | -35.4% |
2013 FY | 5.66 Million MYR | 53.51% |
2013 Q1 | -3.34 Million MYR | -157.98% |
2012 Q3 | 3.59 Million MYR | 293.7% |
2012 FY | 3.68 Million MYR | 228.61% |
2012 Q1 | -3.82 Million MYR | -197.85% |
2012 Q4 | 5.77 Million MYR | 60.35% |
2012 Q2 | -1.85 Million MYR | 51.42% |
2011 Q1 | -307 Thousand MYR | -132.18% |
2011 Q2 | -1.67 Million MYR | -444.63% |
2011 Q4 | 3.9 Million MYR | 583.79% |
2011 FY | 1.12 Million MYR | 152.45% |
2011 Q3 | -808 Thousand MYR | 51.67% |
2010 FY | -2.13 Million MYR | -118.25% |
2010 Q2 | -2.35 Million MYR | 0.0% |
2010 Q3 | -1.86 Million MYR | 20.69% |
2010 Q4 | 954 Thousand MYR | 151.1% |
2009 Q4 | 3.76 Million MYR | 75.67% |
2009 Q3 | 2.14 Million MYR | 0.0% |
2009 FY | 11.72 Million MYR | 28.46% |
2008 FY | 9.12 Million MYR | 11.28% |
2007 FY | 8.19 Million MYR | -14.59% |
2006 FY | 9.6 Million MYR | -3.88% |
2005 FY | 9.98 Million MYR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Duopharma Biotech Berhad | 52.64 Million MYR | 15.289% |